Hai‐Dong Zhu

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang et al. · Signal Transduction and Targeted Therapy · 2023 · 283 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Conventional stents versus stents loaded with 125iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial

Hai‐Dong Zhu, Jin‐He Guo, Aiwu Mao et al. · The Lancet Oncology · 2014 · 151 citations

Medicine, Oncology, Surgery +6

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Comparative genomic and transcriptomic analyses uncover the molecular basis of high nitrogen-use efficiency in the wheat cultivar Kenong 9204

Xiaoli Shi, Fa Cui, Xinyin Han et al. · Molecular Plant · 2022 · 141 citations

Life Sciences, Agronomy, Plant Sciences +17

Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial

Hai‐Dong Zhu, Jin‐He Guo, Ming Huang et al. · Journal of Hepatology · 2018 · 108 citations

Medicine, Radiation Oncology, Surgery +17